ISSN 3080-7638(Print)
ISSN 3080-7646(Online)
版权信息

ISSN 3080-7638(Print)
ISSN 3080-7646(Online)
CODEN:SQHAA7
(国际标准连续出版物标识符·全球唯一标识符)
分配机构:美国化学文摘社(CAS)
          国图集团 CIBTC
进口备案刊号:G015Z107
编委会
主编
郑永波
同行评议专家
副主编
徐爱芳/南通市第二人民医院
马燕/广西贺州市人民医院
黄美莹/贵州工商职业学院
李佳怡/姜晨/张海洋
蒋惠如/杨毅宁/冯智博
汪亚坤/王菡侨/李波
(以上排名不分先后顺序)
编委
编委会助理
周鹏
期刊主页
在线投稿
申请编委/副主编/同行评议专家
索引/检索/存档
DOI
ICI World of Journals
哥白尼索引(波兰)

EuroPub 欧洲文献数据库(英国)
Academia.edu 学术界(美国)
范德比尔特大学医学中心(美国)
巴西联邦政府
LivRe科学在线图书馆

Open Access Library(OALib)
开放存取资源图书馆(美国)

RCCSE中国学术期刊收录(武汉大学)
ESJI欧亚科学期刊索引(哈萨克斯坦)
ResearchBib 研究者索引(日本)
KIND CONGRESS KC会议
Sci Online
Baidu Baike 
Editing and Publishing
Quest Press Limited
Address
Unit D, 7th Floor, No. 19, Rua de Pa̍k-chiông Vai, Macau
Telephone
+853 6881 9699
Email
QuestPress@hotmail.com
Web site
http://qkhl.scionline2025.com

  首页 -> 往期阅览-> 2025年
《实用全科护理学》( ISSN3080-7638、EISSN3080-7646 ) 发布者:Quest Press 发布日期:2025/10/9
10.12479/questpress-syqkhlx.20250210 Open Access 下载1 浏览56

 

FOCUS-PDCA在提高结核菌素皮肤试验规范性中的效果分析

侯红芳
甘肃省平凉市崆峒区东关街道办事处过店街社区卫生服务中心,甘肃平凉,744000
摘要:目的 探究 FOCUS-PDCA 在提高结核菌素皮肤试验规范性中的效果。方法 收录 2023.8——2025.8 期间我院接受结核菌素皮肤试验患者,将 2023 年 8 月至 2024 年 7 月期间收录的 150 例患者纳入对照组,实施常规皮试护理及管理方案;2024 年 8 月至 2025 年 8 月期间收录的 150 例患者纳入观察组,应用 FOCUS-PDCA 管理模式;评价组间管理效果差异。结果 注射部位准确率、皮丘形成合格率、注射角度准确率、注射深度控制合格率、注射剂量精确度观察组较对照组更高,P<0.05。皮试操作规范性评分观察组较对照组更高,P<0.05。医护人员操作满意度评分观察组较对照组更高,P<0.05。皮试相关并发症发生率观察组(4.67%)较对照组(12.00%)更低,P<0.05。结论 在结核菌素皮肤试验过程中配合 FOCUS-PDCA 管理模式,对于提高结核菌素皮肤试验规范性及操作达标率、提高医护人员操作满意度的价值显著,且能一定程度上降低并发症发生率,保证皮试安全性。
关健词:结核菌素;皮肤试验;FOCUS-PDCA 管理模式;规范性;达标率;满意度;并发症
Analysis of the Effect of FOCUS-PDCA in Improving the Standardization of Tuberculin Skin Test
Hongfang Hou
Guodian Street Community Health Service Center, Dongguan Street Office, Kongtong District, Pingliang City,Gansu Province,Pingliang, Gansu744000, China
Abstract:Objective Explore the effectiveness of FOCUS-PDCA in improving the standardization of tuberculin skin tests. Methods Patients who underwent tuberculin skin tests in our hospital from August 2023 to July 2024 were included in the control group, and a routine skin test nursing and management plan was implemented; 150 patients enrolled between August 2024 and August 2025 were included in the observation group and subjected to FOCUS-PDCA management mode; Evaluate the differences in management effectiveness between groups.enrolled between August 2024 and August 2025 were included in the observation group and subjected to FOCUS-PDCA management mode; Evaluate the differences in management effectiveness between groups. Results The accuracy of injection site, qualified rate of skin mound formation, accuracy of injection angle, qualified rate of injection depth control, and accuracy of injection dose were higher in the observation group than in the control group, P<0.05。 The observation group had a higher score for the standardization of skin test procedures compared to the control group, P<0.05。 The satisfaction score of medical staff in the observation group was higher than that in the control group, P<0.05。 The incidence of skin test related complications in the observation group (4.67%) was lower than that in the control group (12.00%), P<0.05。Conclusion Cooperating with the FOCUS-PDCA management mode in the process of tuberculin skin testing has significant value in improving the standardization and compliance rate of tuberculin skin testing, increasing the satisfaction of medical staff, and reducing the incidence of complications to a certain extent, ensuring the safety of skin testing.
Keywords : Tuberculin; Skin test; FOCUS-PDCA management mode; Normality; Compliance rate; Satisfaction; complication
论文收录证明 / 文献检索报告
Document Retrieval Certificate / Proof of Publication Indexing
作者贡献声明 / 贡献确认书
Author Contribution Statement / Certificate of Authorship Contribution
同行评审报告 / 评审意见
Peer Review Report / Peer Review Comments
利益冲突
Conflict of Interest
作者声明不存在任何利益冲突。
The author declares no conflict of interest.
版权声明
Copyright Statement
本文采用知识共享“署名 4.0 国际”许可 (CC BY 4.0) 进行许可。许可协议详情请访问: https://creativecommons.org/licenses/by/4.0/
This article is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). For details of the license, please visit:https://creativecommons.org/licenses/by/4.0/.
 
  Peer Review
同行评审
Editorial Services
编辑服务
Research Ethics Policy
研究伦理政策
Contributorship & Authorship
贡献者与署名
About Quest Press / Macau Sino Int. Med. Press
关于 Quest Press 与 Macau Sino Int. Med. Press
  Global Indexing
全球索引
Copyright Licensing
版权许可
Data Sharing Policy
数据共享政策
Appeal/Correction/Retraction
申诉/更正/撤回
  Online Submission
线上投稿
To the Librarian
致图书馆员
Open Access Statement
开放获取声明
Misconduct Handling Policy
处理不端行为政策
  Content Licensing
内容许可
Guidelines for Reviewers
审稿人指南
Quality Control Mechanism
质量把控机制
Academic Misconduct Screening Policy
学术不端筛查政策
  Advertising Policy
广告政策
Article Processing Charge (APC)
文章处理费
Publication Ethics Policy
出版伦理政策
Call for Editorial Board Members/Associate Editors/Peer Reviewers/Editors-in-Chief
诚邀编委、副主编、同行评审专家及主编